MEROPOINT

MEROPOINT – Meropenem is a broad-spectrum antibacterial agent of the carbapenem family, indicated as empirical therapy prior to the identification of causative organisms, or for disease caused by single or multiple susceptible bacteria in both adults and children with a broad range of serious infections. It works by stopping the growth of bacteria.

COMPOSITION:

Meropenem 1 gm Injection

MODE OF ACTION:

Cause rapid bacterial cell death by covalently binding to penicillin-binding proteins (PBPs) involved in the biosynthesis of mucopeptides in bacterial cell walls. Bactericidal effects result through inhibition of cellular growth and division and the loss of cell wall integrity, eventually causing cell wall lysis. The primary target is PBP 2.

INDICATIONS

In Skin and Skin Structure Infections, Intra-abdominal Infections, Bacterial Septicemia, Urinary Tract Infections, Bacterial Meningitis, Lower Respiratory Tract Infections.

DOSAGE

1 g IV every 8 hours. Clinical practice guidelines recommend meropenem for 4 to 7 days for severe or high-risk community-acquired infections or complicated health-care associated infections.

DISCLAIMER

This information is for the medical professionals & registered medical practitioners only. This product must be consumed with the valid prescription of registered medical practitioners.*Images/Pack are for representation purpose only.